Neuland Laboratories promoter Davuluri Saharsh Rao has disclosed the creation of an encumbrance on his shareholding in the pharmaceutical company. The disclosure was made on March 26, 2026, in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011.

Share Pledge Details

Davuluri Saharsh Rao, who serves as Vice Chairman & Managing Director of Neuland Laboratories, has pledged 96,000 shares to Aditya Birla Money Limited. The pledge was created on March 25, 2026, for personal borrowing purposes.

Promoter Holdings Overview

Prior to this pledge creation, Davuluri Saharsh Rao held 1,95,125 shares representing 1.52% of the company's total share capital with no existing encumbered holdings. Post the pledge creation, his total encumbered shareholding stands at 96,000 shares or 0.75% of the total share capital.

Regulatory Compliance

The disclosure was submitted to both BSE Limited and National Stock Exchange of India Limited, where Neuland Laboratories shares are listed. The company trades under scrip code 524558 on BSE and NEULANDLAB on NSE. This disclosure ensures transparency regarding promoter shareholding changes and compliance with securities market regulations.

The encumbrance represents approximately 49.20% of Davuluri Saharsh Rao's total shareholding in the company, created through a pledge arrangement with Aditya Birla Money Limited for personal financing requirements.

Neuland Laboratories Limited has issued a Letter of Confirmation in lieu of lost share certificates to a shareholder, as communicated to stock exchanges on March 19, 2026. The pharmaceutical company informed both BSE Limited and the National Stock Exchange of India about this regulatory compliance action.

Regulatory Compliance Details

The issuance was conducted pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-RTAMB/P/CIR/2022/8 dated January 25, 2022. This regulatory framework governs the process for handling lost or misplaced share certificates and ensures proper documentation and disclosure to exchanges.

Share Certificate Details

The company approved the issuance of Letter of Confirmation for the following shareholder details:

Exchange Communication

The communication was addressed to both major Indian stock exchanges where Neuland Laboratories shares are listed. BSE Limited received the notification at Phiroze Jeejeebhoy Towers, while the National Stock Exchange of India was informed at their Exchange Plaza location in Bandra Kurla Complex. The company's scrip codes are 524558 on BSE and NEULANDLAB in the EQ series on NSE.

Corporate Governance

Company Secretary Sarada Bhamidipati signed the official communication on behalf of Neuland Laboratories Limited. The document was digitally signed on March 19, 2026, at 11:58:54 +05'30', demonstrating the company's commitment to digital documentation and regulatory compliance. This disclosure ensures transparency and maintains proper records for investor protection and regulatory oversight.